Market Overview

Wednesday's Big Winner: Guardion Health Sciences

Wednesday's Big Winner: Guardion Health Sciences

Guardion Health Sciences, Inc (NASDAQ: GHSI) shares are trading higher after the company announced it received a patent from the Patents Registry in Hong Kong for its proprietary medical device, the MapcatSF.

The MapcatSF measures the macular pigment density in the human eye, thus facilitating treatment for several ocular conditions and diseases that affect a large number of patients.

“The granting of this patent in Hong Kong represents an important step in Guardion’s process to expand into the large Asian markets, where evidenced-based eye care is of great interest to both physicians and consumers,” says David Evans, Guardion’s chief science officer in a statement.

Guardion Health Sciences traded higher by 148% to $2.37 at time of publication.

Related Links:

Ohr Pharmaceutical Merger With Neubase Therapeutics Approved By Shareholders

CareTrust REIT Buys A Skilled Nursing Facility In Idaho For $12.8M

Posted-In: News Legal Movers Trading Ideas Best of Benzinga


Related Articles (GHSI)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Report: eBay Sale Of StubHub Could Be Forthcoming

Harvest One Cannabis Strikes Supply Agreement With GenCanna